- Home
- CELC vs FC Comparison
CELC vs FC Comparison
Compare CELC & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- FC
- Stock Information
- Founded
- CELC 2011
- FC 1983
- Country
- CELC United States
- FC United States
- Employees
- CELC N/A
- FC N/A
- Industry
- CELC Medical Specialities
- FC Other Consumer Services
- Sector
- CELC Health Care
- FC Consumer Discretionary
- Exchange
- CELC Nasdaq
- FC Nasdaq
- Market Cap
- CELC 594.7M
- FC 507.2M
- IPO Year
- CELC 2017
- FC 1992
- Fundamental
- Price
- CELC $12.66
- FC $35.86
- Analyst Decision
- CELC Strong Buy
- FC Strong Buy
- Analyst Count
- CELC 6
- FC 3
- Target Price
- CELC $29.17
- FC $63.33
- AVG Volume (30 Days)
- CELC 257.7K
- FC 55.7K
- Earning Date
- CELC 11-14-2024
- FC 01-02-2025
- Dividend Yield
- CELC N/A
- FC N/A
- EPS Growth
- CELC N/A
- FC 40.32
- EPS
- CELC N/A
- FC 1.74
- Revenue
- CELC N/A
- FC $287,233,000.00
- Revenue This Year
- CELC N/A
- FC $7.22
- Revenue Next Year
- CELC N/A
- FC $16.28
- P/E Ratio
- CELC N/A
- FC $20.61
- Revenue Growth
- CELC N/A
- FC 2.39
- 52 Week Low
- CELC $11.51
- FC $33.75
- 52 Week High
- CELC $22.19
- FC $44.96
- Technical
- Relative Strength Index (RSI)
- CELC 28.22
- FC 36.32
- Support Level
- CELC $15.33
- FC $35.58
- Resistance Level
- CELC $16.14
- FC $40.15
- Average True Range (ATR)
- CELC 0.97
- FC 1.37
- MACD
- CELC -0.28
- FC -0.43
- Stochastic Oscillator
- CELC 22.85
- FC 3.26
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About FC Franklin Covey Company
Franklin Covey Co is a global company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education practice, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the United States and other international countries.